Y Intercept Hong Kong Ltd Takes Position in Exponent, Inc. $EXPO

Y Intercept Hong Kong Ltd purchased a new stake in Exponent, Inc. (NASDAQ:EXPO) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 56,587 shares of the business services provider’s stock, valued at approximately $4,228,000. Y Intercept Hong Kong Ltd owned about 0.11% of Exponent as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in shares of Exponent by 1.2% during the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,791,747 shares of the business services provider’s stock valued at $388,419,000 after acquiring an additional 55,190 shares in the last quarter. Geneva Capital Management LLC boosted its holdings in shares of Exponent by 11.2% during the 1st quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider’s stock valued at $141,517,000 after acquiring an additional 176,152 shares in the last quarter. Resona Asset Management Co. Ltd. boosted its holdings in shares of Exponent by 17.3% during the 1st quarter. Resona Asset Management Co. Ltd. now owns 506,784 shares of the business services provider’s stock valued at $41,250,000 after acquiring an additional 74,605 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of Exponent by 2.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 441,646 shares of the business services provider’s stock valued at $35,800,000 after acquiring an additional 8,501 shares in the last quarter. Finally, Millennium Management LLC boosted its holdings in shares of Exponent by 543.1% during the 1st quarter. Millennium Management LLC now owns 305,230 shares of the business services provider’s stock valued at $24,742,000 after acquiring an additional 257,766 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a report on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Insider Buying and Selling

In related news, VP Joseph Sala sold 1,595 shares of the company’s stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Catherine Corrigan sold 4,930 shares of the firm’s stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of $66.82, for a total value of $329,422.60. Following the completion of the transaction, the chief executive officer directly owned 82,753 shares of the company’s stock, valued at $5,529,555.46. The trade was a 5.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 16,326 shares of company stock worth $1,133,059 in the last 90 days. Company insiders own 1.60% of the company’s stock.

Exponent Price Performance

Shares of Exponent stock opened at $67.42 on Wednesday. Exponent, Inc. has a one year low of $63.81 and a one year high of $112.75. The firm has a market capitalization of $3.40 billion, a price-to-earnings ratio of 33.71 and a beta of 0.91. The business has a 50-day simple moving average of $69.36 and a 200 day simple moving average of $73.28.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.04. The firm had revenue of $132.87 million during the quarter, compared to analyst estimates of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The company’s revenue for the quarter was up 7.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.57 EPS. On average, sell-side analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.

About Exponent

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.